IMARA Inc. Uncategorized Contracts & Agreements

13 Contracts & Agreements
Recent Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
Description of the Registrants Securities
IMARA Inc.
Pharmaceuticals
2024
Open Market Sale AgreementSM, dated June 23, 2023, by and between Enliven Therapeutics, Inc. and Jefferies LLC
IMARA Inc.
Pharmaceuticals
NY
2023
Amended and Restated 2020 Plan
IMARA Inc.
Pharmaceuticals
DE
2023
Contingent Value Rights Agreement between the Company and Rights Agent
IMARA Inc.
Pharmaceuticals
DE
2023
Letter Agreement, dated as of January 27, 2023, by and among the Registrant, Rahul Ballal, Michael Gray and Enliven Therapeutics, Inc
IMARA Inc.
Pharmaceuticals
2023
First Amendment to the Letter Agreement, dated as of November 5, 2021, by and between the Registrant and Kenneth M. Attie, M.D
IMARA Inc.
Pharmaceuticals
2022
Letter Agreement, dated as of December 4, 2020, by and between the Registrant and Kenneth M. Attie, M.D
IMARA Inc.
Pharmaceuticals
MA
2022
First Amendment to the Amended and Restated Letter Agreement, dated as of November 5, 2021, by and between the Registrant and Michael P. Gray
IMARA Inc.
Pharmaceuticals
2021
First Amendment to the Amended and Restated Letter Agreement, dated as of November 5, 2021, by and between the Registrant and Rahul D. Ballal, Ph.D
IMARA Inc.
Pharmaceuticals
2021
Description of Securities of the Registrant
IMARA Inc.
Pharmaceuticals
2021
Amended and Restated Letter Agreement, dated as of September 23, 2019, by and between the Registrant and Michael P. Gray
IMARA Inc.
Pharmaceuticals
MA
2020
Amended and Restated Letter Agreement, dated as of September 23, 2019, by and between the Registrant and Willem H. Scheele, M.D
IMARA Inc.
Pharmaceuticals
MA
2020
Amended and Restated Letter Agreement, dated as of September 23, 2019, by and between the Registrant and Rahul D. Ballal, Ph.D
IMARA Inc.
Pharmaceuticals
MA
2020